Resistin-like molecule α decreases glucose tolerance during intestinal inflammation

Journal of Immunology

Volumn 182, Issue 4, 2009, Pages 2357-2363

  Munitz, Ariel ^b   Seidu, Luqman ^a   Cole, Eric T ^a   Ahrens, Richard ^a   Hogan, Simon P ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; EOTAXIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 5; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE YY; POLYPEPTIDE; RANTES; RESISTIN; RESISTIN LIKE MOLECULE ALPHA; RESISTIN LIKE MOLECULE GAMMA; UNCLASSIFIED DRUG; CYTOKINE; RETNLA PROTEIN, MOUSE; SIGNAL PEPTIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; EOSINOPHIL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; CHEMICALLY INDUCED DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; COLITIS; CYTOKINES; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 61449221902     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803130     Document Type: Article

References (38)

1. Kim, K. H., K. Lee, Y. S. Moon, and H. S. Sul. 2001. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276: 11252-11256.
2. Banerjee, R. R., S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, et al. 2004. Regulation of fasted blood glucose by resistin. Science 303: 1195-1198.
3. Patel, S. D., M. W. Rajala, L. Rossetti, P. E. Scherer, and L. Shapiro. 2004. Disulfide-dependent multimeric assembly of resistin family hormones. Science 304: 1154-1158.
4. Banerjee, R. R., and M. A. Lazar. 2001. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J. Biol. Chem. 276: 25970-25973.
5. Rajala, M. W., S. Obici, P. E. Scherer, and L. Rossetti. 2003. Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest. 111: 225-230.
6. Nair, M. G., K. J. Guild, and D. Artis. 2006. Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J. Immunol. 177: 1393-1399.
7. Holcomb, I. N., R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19: 4046-4055.
8. Liu, T., S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, and S. H. Phan. 2004. FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 164: 1315-1326.
9. Karmiris, K., I. E. Koutroubakis, C. Xidakis, M. Polychronaki, T. Voudouri, and E. A. Kouroumalis. 2006. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm. Bowel Dis. 12: 100-105.
10. Konrad, A., M. Lehrke, V. Schachinger, F. Seibold, R. Stark, T. Ochsenkuhn, K. G. Parhofer, B. Goke, and U. C. Broedl. 2007. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur. J. Gastroenterol. Hepatol. 19: 1070-1074.
11. Gardiner, J. V., C. N. Jayasena, and S. R. Bloom. 2008. Gut hormones: a weight off your mind. J. Neuroendocrinol. 20: 834-841.
12. Besterman, H. S., C. N. Mallinson, R. Modigliani, N. D. Christofides, A. Pera, V. Ponti, D. L. Sarson, and S. R. Bloom. 1983. Gut hormones in inflammatory bowel disease. Scand. J. Gastroenterol. 18: 845-852.
13. Hogan, S. P., L. Seidu, C. Blanchard, K. Groschwitz, A. Mishra, M. L. Karow, R. Ahrens, D. Artis, A. J. Murphy, D. M. Valenzuela, et al. 2006. Resistin-like molecule β regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118: 257-268.
14. McVay, L. D., S. A. Keilbaugh, T. M. Wong, S. Kierstein, M. E. Shin, M. Lehrke, M. I. Lefterova, D. E. Shifflett, S. L. Barnes, F. Cominelli, et al. 2006. Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116: 2914-2923.
15. Munitz, A., A. Waddell, L. Seidu, E. T. Cole, R. Aherens, S. P. Hogan, and M. E. Rothenberg. 2008. Resistin like molecule α enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 122: 1200-1207.
16. Forbes, E., M. Hulett, R. Ahrens, N. Wagner, V. Smart, K. I. Matthaei, E. B. Brandt, L. A. Dent, M. E. Rothenberg, M. Tang, et al. 2006. ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. J. Leukocyte Biol. 80: 330-341.
17. Siegmund, B., H. A. Lehr, and G. Fantuzzi. 2002. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122: 2011-2025.
18. Sitaraman, S., X. Liu, L. Charrier, L. H. Gu, T. R. Ziegler, A. Gewirtz, and D. Merlin. 2004. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J. 18: 696-698.
19. Suzuki, A., T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193: 471-481.
20. Ahrens, R., A. Waddell, L. Seidu, C. Blanchard, R. Carey, E. Forbes, M. Lampinen, T. Wilson, E. Cohen, K. Stringer, et al. 2008. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 181: 7390-7399.
21. Macdonald, T. T., and G. Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307: 1920-1925.
22. Abelson, P., and D. Kennedy. 2004. The obesity epidemic. Science 304: 1413.
23. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3: 715-720.
24. Sutherland, T. J., J. O. Cowan, S. Young, A. Goulding, A. M. Grant, A. Williamson, K. Brassett, G. P. Herbison, and D. R. Taylor. 2008. The association between obesity and asthma: interactions between systemic and airway inflammation. Am. J. Respir. Crit. Care Med. 178: 469-475.
25. Fantuzzi, G. 2008. Adiponectin and inflammation: consensus and controversy. J. Allergy Clin. Immunol. 121: 326-330.
26. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. 5: 953-964.
27. Chaudhri, O. B., V. Salem, K. G. Murphy, and S. R. Bloom. 2008. Gastrointestinal satiety signals. Annu. Rev. Physiol. 70: 239-255.
28. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
29. Myers, M. G., M. A. Cowley, and H. Munzberg. 2008. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70: 537-556.
30. Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115: 911-919, quiz 920.
31. Batterham, R. L., M. A. Cohen, S. M. Ellis, C. W. Le Roux, D. J. Withers, G. S. Frost, M. A. Ghatei, and S. R. Bloom. 2003. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349: 941-948.
32. Le Roux, C. W., R. L. Batterham, S. J. Aylwin, M. Patterson, C. M. Borg, K. J. Wynne, A. Kent, R. P. Vincent, J. Gardiner, M. A. Ghatei, and S. R. Bloom. 2006. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147: 3-8.
33. Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
34. Kim, F., M. Pham, I. Luttrell, D. D. Bannerman, J. Tupper, J. Thaler, T. R. Hawn, E. W. Raines, and M. W. Schwartz. 2007. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100: 1589-1596.
35. Hass, D. J., C. M. Brensinger, J. D. Lewis, and G. R. Lichtenstein. 2006. The impact of increased body mass index on the clinical course of Crohn's disease. Clin. Gastroenterol. Hepatol. 4: 482-488.
36. Blain, A., S. Cattan, L. Beaugerie, F. Carbonnel, J. P. Gendre, and J. Cosnes. 2002. Crohn's disease clinical course and severity in obese patients. Clin. Nutr. 21: 51-57.
37. Al-Azzawi, H. H., A. Mathur, D. Lu, D. A. Swartz-Basile, A. Nakeeb, and H. A. Pitt. 2007. Resistin-like molecule α reduces gallbladder optimal tension. J. Gastrointest. Surg. 11: 95-100.
38. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.